{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:57:04Z","timestamp":1753441024665,"version":"3.37.3"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2013-02359069"],"award-info":[{"award-number":["GR-2013-02359069"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>On March 2019 the World Health Organization declared Coronavirus disease (COVID-19) pandemic. Several recent reports disclose that the outcome of the infection is related to age, sex and can be influenced by underlying clinical conditions. Parkinson\u2019s disease (PD) and other parkinsonisms are the most common chronic disease which can cause, directly or indirectly, the patient to be more exposed to other diseases, mostly respiratory system\u2019s ones. Our primary outcome is to evaluate if PD patients are more susceptible than non-PD to take COVID-19 infection. Second, to detect if the infection course is worse in PD-COVID+ patients versus non-PD. This is a retrospective observational study on a cohort of 18 patients (13 PD\u2013 5 non-PD), hospitalized in a Rehabilitative Unit during the occurrence of SARS-CoV2 epidemic outbreak. All patients performed laboratory tests, lung Computed Tomography (CT) and have been tested for COVID-19 thorough pharyngeal swab. PD and non-PD groups were comparable for age, gender and Hoehn and Yahr stage. Seventy-seven (77)% of PD and 60% of non-PD resulted positive for COVID-19. PD-COVID+ and PD-COVID- did not differ for age, disease duration and L-dopa daily dose. PD COVID-19+ subjects were mainly asymptomatic (50%) while non-PD ones were all symptomatic, mostly with respiratory difficulties. PD doesn\u2019t seem to be a risk factor to take SARS-COV2 infection, even if our study is related to a limited sample size. Our results, together with those of other recent studies, highlight the need to evaluate the actual susceptibility of patients with Parkinson\u2019s disease to develop COVID-19 disease, and how the infection may influence the risk of clinical worsening and increase of mortality.<\/jats:p>","DOI":"10.1371\/journal.pone.0251313","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T17:53:29Z","timestamp":1620323609000},"page":"e0251313","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study"],"prefix":"10.1371","volume":"16","author":[{"given":"Chiara","family":"Sorbera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Brigand\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0282-405X","authenticated-orcid":true,"given":"Lilla","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosella","family":"Ciurleo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Placido","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"pone.0251313.ref001","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19: 11 March 2020 [online]. Available at: https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19\u201411-march-2020. Accessed March 30, 2020."},{"key":"pone.0251313.ref002","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/d41586-020-00758-2","article-title":"EStoye, JTollefson. The coronavirus pandemic in five powerful charts","volume":"579","author":"E Callaway","year":"2020","journal-title":"Nature"},{"key":"pone.0251313.ref003","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","author":"YC Li","year":"2020","journal-title":"J Med Virol"},{"key":"pone.0251313.ref004","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/infdis\/jiv499","article-title":"Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4","volume":"213","author":"K Li","year":"2016","journal-title":"J Infect Dis"},{"key":"pone.0251313.ref005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1354\/vp.41-2-101","article-title":"The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice","volume":"41","author":"K Matsuda","year":"2004","journal-title":"Vet Pathol"},{"key":"pone.0251313.ref006","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Q Li","journal-title":"N Engl J Med"},{"key":"pone.0251313.ref007","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus disease (COVID-19) e China","author":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team","year":"2020","journal-title":"China CDC Weekly"},{"key":"pone.0251313.ref008","article-title":"Clinical characteristics of 2019 novel coronavirus infection in China","author":"WJ Guan","year":"2020","journal-title":"medRxiv"},{"key":"pone.0251313.ref009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12883-017-0904-4","article-title":"Co-morbidity and polypharmacy in Parkinson\u2019s disease: insights from a large Scottish primary care database","volume":"17","author":"G McLean","year":"2017","journal-title":"BMC Neurology"},{"key":"pone.0251313.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2018.04.031","article-title":"Cardiac abnormalities in Parkinson\u2019s disease and Parkinsonism","volume":"53","author":"FA Scorza","year":"2018","journal-title":"J Clin Neurosci"},{"key":"pone.0251313.ref011","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.parkreldis.2018.09.001","article-title":"Dyspnea: An underestimated symptom in Parkinson\u2019s disease","volume":"60","author":"G Baille","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"pone.0251313.ref012","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00702-019-02055-3","article-title":"Motor and non-motor function predictors of mortality in Parkinson\u2019s disease","volume":"126","author":"P Bugalho","year":"2019","journal-title":"J Neural Transm (Vienna)"},{"key":"pone.0251313.ref013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2020.02.018","article-title":"Factors associated with hospitalisation among people with Parkinson\u2019s disease\u2014A systematic review and meta-analysis","volume":"71","author":"O Okunoye","journal-title":"Parkinsonism Relat Disord"},{"key":"pone.0251313.ref014","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.parkreldis.2010.04.010","article-title":"The cause of death in idiopathic Parkinson\u2019s disease","volume":"16","author":"S Pennington","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"pone.0251313.ref015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JPD-202038","article-title":"The Impact of the COVID-19 Pandemic on Parkinson\u2019s Disease: Hidden Sorrows and Emerging Opportunities.","volume":"10","author":"RC Helmich","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"pone.0251313.ref016","article-title":"Impact of the COVID-19 pandemic on Parkinson\u2019s disease and movement disorders","author":"SM Papa","year":"2020","journal-title":"Mov Disord"},{"issue":"8","key":"pone.0251313.ref017","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jnnp-2017-316437","article-title":"Efficacy of intensive multidisciplinary rehabilitation in Parkinson\u2019s disease: a randomised controlled study","volume":"89","author":"D Ferrazzoli","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"pone.0251313.ref018","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1545968314542981","article-title":"Intensive rehabilitation treatment in early Parkinson\u2019s disease: a randomized pilot study with a 2-year follow-up","volume":"29","author":"G Frazzitta","year":"2015","journal-title":"Neurorehabil Neural Repair"},{"key":"pone.0251313.ref019","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00455-015-9671-9","article-title":"Dysphagia in Parkinson\u2019s Disease.","volume":"31","author":"I. Suttrup","year":"2016","journal-title":"Dysphagia"},{"key":"pone.0251313.ref020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2018.08.002","article-title":"Chemosensory perception is specifically impaired in Parkinson\u2019s disease","volume":"57","author":"C Tremblay","year":"2018","journal-title":"Parkinsonism Relat., Disord"},{"key":"pone.0251313.ref021","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28104","article-title":"Outcome of Parkinson\u2019s Disease Patients Affected by COVID-19","author":"A Antonini","year":"2020","journal-title":"Mov Disord"},{"key":"pone.0251313.ref022","article-title":"Drooling in Parkinson\u2019s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study","author":"DJ Van Wamelen","year":"2020","journal-title":"Dysphagia"},{"issue":"7","key":"pone.0251313.ref023","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/mds.28176","article-title":"COVID-19 in Parkinson\u2019s Disease Patients Living in Lombardy, Italy.","volume":"35","author":"A Fasano","year":"2020","journal-title":"Mov Disord."},{"key":"pone.0251313.ref024","article-title":"Effects of COVID-19 on Parkinson\u2019s Disease Clinical Features: A Community-Based Case-Control Study","author":"R Cilia","year":"2020","journal-title":"Mov Disord"},{"key":"pone.0251313.ref025","article-title":"Coronavirus Disease 2019 Case Fatality and Parkinson\u2019s Disease","author":"Q Zhang","year":"2020","journal-title":"Movement Disorders"},{"key":"pone.0251313.ref026","article-title":"Phenomenology and Outcomes of In-Patients With Parkinson\u2019s Disease During the Coronavirus Disease 2019 Pandemic","author":"C Kobylecki","year":"2020","journal-title":"Movement Disorders"},{"key":"pone.0251313.ref027","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2020.08.012","article-title":"dictors of COVID-19 outcome in Parkinson\u2019s disease","volume":"78","author":"A Fasano","year":"2020","journal-title":"PreParkinsonism & related disorders"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T17:54:05Z","timestamp":1620323645000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251313"}},"subtitle":[],"editor":[{"given":"Joohyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0251313","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}